Literature cited
Yu. V. Anshelevich and T. A. Sorokina, Kardiologiya, No. 10, 54–57 (1980).
V. A. Bondarenko, K. A. Zaitseva, E. E. Mikhlina, et al., Khim.-farm. Zh., No, 11, 56–60 (1978).
V. R. Briskin and V. G. Storozhuk, Kardiologiya, No. 10, 103–105 (1981).
B. E. Votchal, I. P. Zamotaev, L. G. Lozinskii, et al., Ter. Arkh., No. 8, 10–14 (1973).
B. E. Votchal and L. G. Lozinskii, Klin. Med., No. 10, 16–21 (1971).
É. I. Gendenshtein, Farmakol. Toksikol, No. 3, 303–305 (1970).
S. P. Golitsyn and S. F. Sokolov, Kardiologiya, No. 11, 5–8 (1983).
E. T. Gneushev, A. K. Starodubtsev, A. P. Kurapov, et al., Farmakol. Toksikol., No. 3, 107–110 (1982).
V. S. Gurevich and N. I. Razumoyskaya, Ibid., No. 10, 114–119 (1984).
V. L. Doshchitsyn, Kardiologiya, No. 9, 80–86 (1970).
V. L. Doschitsyn, Ibid., No. 1, 30–37 (1975).
M. A. Dumpis and N. I. Kudryashova, Khim.-farm. Zh., No. 10, 1159–1169 (1983).
S. V. Zhuravlev and A. N. Gritsenko, Zh. Obshch. Khim.,26, 3385–3391 (1956).
I. P. Zamotaev, L. G. Lozinskii, and B. L. Sandomirskii, Kardiologiya, No. 8, 93–97 (1974).
R. M. Zaslavskaya, I. F. Skorobogataya, and É. Ya. Kolbanovskaya, Sov. Med., No. 5, 59–62 (1969).
N. V. Kaverina, Z. P. Senova, Yu. I. Vikhlyaev, and O. V. Ul'yanova, Farmakol. Toksikol., No. 6, 693–698 (1970).
N. V. Kaverina, Z. P. Senova, V. S. Mitrofanov, and M. F. Runova, Ibid., No. 2, 182–185 (1972).
N. V. Kaverina, A. P. Skoldinov, M. M. Dzhaparidze, et al., Ibid., No. 5, 25–28 (1984).
D. F. Kesler, Klin, Med., No. 8, 63–64 (1973).
V. G. Kukes, A. S. Smetnev, E. L. Ponomarenko, et al., Kardiologiya, No. 11, 45–47 (1983).
R. D. Kurbanov and N. A. Mazur, Ibid., No. 10, 59–64 (1981).
M. S. Kushakovskii, Ibid., No. 5, 5–9 (1984).
V. P. Lanskii, Farmakol. Toksikol., No. 5, 550–553 (1973).
Ts. A. Levina, A. I. Romanovskaya, and A. V. Konovalenko, Kardiologiya, No. 4, 142–143 (1973).
N. A. Mazur, Ibid., No. 4, 5–12 (1978).
N. A. Mazur, Klin, Med., No. 5, 68–72 (1982).
N. A. Mazur and V. I. Metelitsa, Farmakol. Toksikol., No. 3, 59–61 (1982).
M. D. Mashkovskii, Drugs [in Russian], 9th Edn., Moscow (1984), pp. 293–301, 400–403.
V. I. Metelitsa, Cardiologist's Handbook of Clinical Pharmacology [in Russian], Moscow (1980), p. 85.
E. E. Mikhlina, V. Ya. Vorob'eva, N. A. Komarova, et al., Khim.-farm. Zh., No. 2, 24–26 (1974).
New Data on the Pharmacology and Clinic of Phenothiazine Derivatives [in Russian], Moscow (1958).
L. I. Ol'binskaya, M. S. Yurina, P. F. Litvitskii, and V. A. Sandrikov, Kardiologiya, No. 12, 10–13 (1980).
V. M. Orlov, V. A. Kruglov, I. R. Nikolaevskii, et al., Klin. Med., No. 1, 57–59 (1982).
O. S. Ryabokon', V. K. Piotrovskii, E. B. Smirnova, et al., Kardiologiya, No. 10, 40–42 (1980).
M. E. Raiskina, Ibid., No. 1, 141–149 (1974).
L. V. Rozenshtraukh, N. V. Kaverina, E. P. Anyukhovskii, et al., Ibid., No. 6, 72–81 (1982).
A. S. Smetnev, Kh. Kh. Shugushev, A. V. Rozenshtraukh, et al., Ter. Arkh., No. 1, 92–95 (1983).
A. V. Sumarokov and A. A. Mikhailov, Heart Arrhythmias [in Russian], Moscow (1976).
N. I. Tatishvili, Z. K. Chkhaidze, B. E. Valiev, et al., in: Problems of Clinical and Experimental Pharmacology and Side Effects of Drugs [in Russian], Tbilisi (1983), pp. 111–112.
D. A. Kharkevich, ed., Advances in the Creation of New Drugs [in Russian], Moscow (1973).
A. P. Tsybusov, Antiarrhythmic Activity of Quaternary Derivatives of Trimecaine. Author's Abstract of Dissertation for the Degree of Candidate of Medical Sciences [in Russian], Yaroslavl' (1981).
E. I. Chazov, Ter. Arkh., No. 5, 33–44 (1975).
E. S. Charnaya and E. T. Beer, Klin. Med., No. 11, 95–96 (1979).
Kh. Kh. Shchugushev, A. S. Smetnev, A. V. Pozenshtraukh, et al., Kardiologiya, No. 5, 71–75 (1982).
Kh. Kh. Shchugushev, A. S. Smetnev, and A. V. Raushenbakh, Ibid., No. 11, 72–78.
S. D. Yuzhakov, Khim.-farm. Zh., No. 5, 68–72 (1980).
Z. I. Yanushkevichus, Kardiologiya, No. 2, 35–41 (1980).
L. N. Yakhontov, M. D. Mashkovskii, and E. E. Mikhlina, Khim.-farm. Zh., No. 12, 23–32 (1980).
G. Aberg, B. Ekenstam, and E. Smith, Arzneimittel-Forsch.,33, 706–710 (1983).
H. J. Adams, G. H. Kronberg, and B. N. Takman, J. Pharm. Sci.,62, 1677–1679 (1973).
G. W. Adelstein, J. Med. Chem.,16, 309–312 (1973).
J. L. Anderson, D. C. Harrison, P. J. Meffin, and R. A. Vinkle, Drugs,15, 271–309 (1978).
J. D. Allen and A. H. Deering, J. Cardiovasc. Pharmacol.,5, 937 (1983).
J. D. Allen, J. M. Kofi, R. G. Shanks, et al., Brit. J. Pharmacol.,39, 183p-184p (1970).
Ann. Drug Data Rep., 306 (1971).
Ibid., p. 365.
Ibid., p. 387.
Ibid., p. 28 (1979/1980).
Ibid., p. 81 (1979/1980).
Ibid., p. 37 (1982).
Ibid., p. 142.
Ibid., p. 224.
Ibid., p. 24 (1983).
Ibid., p. 96.
Ibid., p. 148.
Ibid.,6, Pt 1, p. 2 (1984).
Ibid., p. 178 (1981).
Ibid.,6, Pt 2, pp. 73, 92 (1984).
Ibid., p. 89.
E. E. Bagwell. T. Walle, D. E. Drayer, et al., J. Pharmacol. Exp. Ther.,197, 38–48 (1976).
E. N. Banitt, W. E. Coyne, J. R. Schmid, and A. Mendel, J. Med. Chem.,18, 1130–1134 (1975).
O. A. Beck, H. U. Lehmann, and H. Horchrein, Dtsch. Med. Wschr.,103, 1068–1072 (1978).
O. A. Beck, K. Kramer, R. Wolf, et al., Med. Klin.,70, 95–101 (1975).
O. A. Beck, H. Spielmann, E. Witt, et al., Arzneimittel.-Forsch.,30, 2172–2180 (1980).
O. A. Beck, E. Witt, and H. Hochrein, Z. Kardiol.,64, 179–187 (1975).
A. Beresewicz, B. Pytkowski, G. Sedek, and K. Zdanowski, Pol. J. Pharmacol. Pharm.,35, 223–232 (1983).
J. L. Bergel, T. Sulkovsky, D. R. Much, and R. L. Wendt, Arzneimittel.-Forseh,33, 1258–1268 (1983).
A. Berlin-Wahlen, J. C. Barkus, J. B. Keenaghan, et al., Acta Pharm. Suec.,14, 417–421 (1977).
C. A. Bernhardt, Ch. Condamine, H. Demarne, et al., J. Med. Chem.,23, 1102–1108 (1980).
S. Binecki and A. Bulacinski, Acta Pol. Pharm.,36, 13–16 (1979).
R. L. Blandford, J. Crampton, and H. Kudlac, Brit. Med. J.,284, 16–17 (1982).
W. Bleifeld, S. Effer, and W. Merz, Verh. Dtsch. Ges. Inn. Med.,74, 973–975 (1968).
G. Bonola, P. D. Re, M. J. Magistretti, et al., J. Med. Chem.,11, 1136–1139 (1968).
G. Bourgery, P. Dostert, A. Lacour, et al., Ibid.,24, 159–167 (1981).
B. Brise and F. Bender, Med. Mschr.,31, 412–414 (1977).
B. Brown and P. C. Churchill, J. Pharmacol. Exp. Ther.,225, 372–377 (1983).
W. R. Buckett and F. A. Marwick, Brit. J. Pharmacol.,54, 3–9 (1975).
W. D. Bussmann, H. J. Hanek, and M. Kaltenbach, Dtsch. Med. Wschr.,99, 2443–2445 (1974).
W. D. Bussmann, E. Miller, and M. Kaltenbach, Ibid.,101, 228–231 (1976).
E. W. Byrnes, P. D. Master, E. R. Smith, et al., J. Med. Chem.,22, 1171–1176 (1979).
T. J. Campbell, Vaughan, and E. M. Williams, Brit. J. Pharmacol.,76, 337–345 (1982).
E. Carmeliet, P. A. Y. Janssen, R. Marsboom, et al., Arch. Int. Pharmacodyn.,231, 104–130 (1978).
W. Chen. J. Dong, and G. Ding, Chem. Abstr., 93, 795 (1979).
C. Chepin, L. Kushins, E. Manson, et al., Anesthesiology,53, 23–26 (1980).
G. C. J. Chiou and M. A. McLanghin, Europ. J. Pharmacol.,81, 587–594 (1982).
C. Y. C. Chew, J. Collett, and B. N. Singh, Drugs,17, 161–181 (1979).
G. Cocco and C. Strozzi, Europ. J. Clin. Pharmacol.,14, 105–109 (1978).
P. Danilo and M. R. Rosen, Amer. Heart J.,92, 532–536 (1976).
R. R. Dean and D. M. Ferguson, Arch. Int. Pharmacodyn.,190, 183–189 (1971).
L. S. Dreifus, Z. Filip, D. M. Sexton, et al., Amer. J. Cardiol.,31, 129–133 (1973).
Drugs of the Future,8, 1049 (1983).
Ibid.,9, 34 (1984).
Ibid., 38.
Ibid., 273.
Drugs Today,17, 37 (1981).
P. Duchene-Marullar, Sciences,1, 407–409 (1980).
D. Duran, E. V. Platia, L. S. Griffith, et al., Clin. Pharmacol. Ther.,32, 554–561 (1982).
M. Eckstein and E. Hedregen, Pol. J. Pharmacol. Pharm.,32, 817–821 (1980).
J. D. Ehrhardt, B. Rouot, and J. Schwartz, Europ. J. Med. Chem.,13, 235 (1978).
G. Faust and W. Fiedler, Pharmazie,28, 345–350 (1973).
H. Fiechring, I. Assmann, and H. Schwela, Z. Ges. Inn. Med.,36, 779–788 (1981).
R. Ferrini, G. Miragoli, and G. Croce, Arzneimittel-Forsch.,20, 1074–1079 (1970).
W. Frey, Wien. Klin. Wschr.,55, 849–853 (1918).
R. Gmeiner, K. N. Choi, S. Hamspete, et al., Europ. J. Cardiol.,9, 77–86 (1979).
J. Hamm, E. Hunckohl, and A. Schmidt, Klin. Wschr.,48, 457–464 (1970).
H. J. Hapke and E. Prigge, Arznemittel.-Forsch.,26, 1849–1857 (1976).
A. S. Harris and R. H. Kokernot, Amer. J. Physiol.,163, 505–516 (1950).
M. Hollmann, E. Brode, D. Hotz, et al., Arzneimittel.-Forsch.,33, 763–770 (1983).
B. Holmes, R. N. Brodgen, R. C. Heel, et al., Drugs,26, 93–123 (1983).
S. J. Hopkins, Drugs of Future,2, 12 (1977).
R. I. Horwitz and A. R. Feinstein, J. A. M. A.,246, 2455 (1981).
K. Ito, S. Kamakura, and H. Koike, Arch. Int. Pharmacodyn.,244, 73–85 (1980).
E. Jänchen, H. Bechtold, W. Kasper, et al., Clin. Pharmacol. Ther.,26, 187–195 (1979).
J. A. M. A.,213, 1326 (1970).
D. K. Jung, M. M. Vohza, and I. Chu, J. Pharm. Sci.,59, 1405–1409 (1970).
G. Kaufmann, Schweiz. Med. Wschr.,111, 1684–1687 (1981).
J. Keck, Z. Naturforsch.,18B, 177–179 (1963).
L. D. D. Keefe, R. E. Kates, and D. C. Harrison, Drugs,22, 363–400 (1981).
H. Kesteloot, F. van de Werf, B. Marchandise, and R. Sluyts, Acta Cardiol. (Brux.),34, 301–309 (1979).
H. Kesteloot and R. Stroobandt, Arch. Int. Pharmacodyn.,230, 225–234 (1977).
T. Kimura, M. Endoh, N. Taira, et al., Experientia,28, 813–814 (1972).
W. Kobinger, C. Lillie, and L. Pichler, Naunyn Schmiedeberg's Arch. Pharmacol.,306, 255–262 (1979).
W. Kobinger, C. Lillie, and L. Pichler, Europ. J. Pharmacol.,58, 141–150 (1979).
W. Kobinger and C. Lillie, Ibid.,64, 209–220 (1981).
M. J. Kornet and P. A. Thio, J. Pharm. Sci.,58, 724 (1969).
M. J. Kornet, P. A. Thio, N. Malone, et al., Ibid.,64, 639–642 (1975).
R. Krähenmann and P. Heistracher, Naunyn-Schmiedeberg's Arch. Pharmacol.,311, 36R (1980).
K. F. Lang, H. Jast, and P. Limbourg, Z. Kardiol.,64, 389–395 (1975).
B. Levy and M. Wasserman, Brit. J. Pharmacol.,39, 139–147 (1970).
T. K. Lin, Y. W. Chien, R. R. Dean, et al., J. Med. Chem.,17, 751–753 (1974).
L. Liangquan, Q. Zhixiang, W. Zhimin, et al., Sci. Sin. (Engl. Ed),22, 1220 (1979).
B. Lown, A. M. Fakhro, W. B. Hood, Jr., et al., J.A.M.A.109, 188–198 (1967).
B. R. Lucchesi et al., J. Pharmacol. Exp. Ther.,199, 310–328 (1976).
B. R. Madan, V., Madan, V. K. Pendse, and R. S. Gupta, Arch. Int.- Pharmacodyn.,105, 53–65 (1970).
F. R. Mantz, J. Thorac. Surg.,5, 612–628 (1936).
L. C. Mark, J. J. Kayder, J. M. Steele, et al., J. Pharmacol. Exp. Ther.,102, 5–15 (1951).
R. J. Marshall and J. A. Ojewole, Toxicol. Appl. Pharmacol.,46, 759–768 (1978).
R. J. Marshall and J. R. Parratt, Brit. J. Pharmacol.,55, 359 (1975); 61, 315–317 (1977).
P. D. McMaster, E. W. Byrnes, H. S. Feldman, et al., J. Med. Chem.,22, 1177 (1979).
E. O. R. Medina, Ch. Fisch, R. Bernard, et al., Cardiology, No. 12, 86–89 (1982).
T. Meinertz, W. Kasper, F. Kersting, et al., Clin. Pharmacol. Ther.,26, 196–206 (1979).
M. Moyahara, O. Itimura, M. Yokoyama, et al., Tohoku J. Exp. Med.,97, 95–96 (1969).
C. M. Mokler and C. G. Van Arman, J. Pharmacol. Exp. Ther.,136, 114–124 (1962).
B. B. Molioy and M. I. Steinberg, Life Sci.,25, 1397 (1979).
M. Montochef, Coeur,5, 659–662 (1974).
S. E. N. Moore, J. F. Spear, L. N. Horowitz, et al., Amer. J. Cardiol.,41, 703 (1978).
P. H. Morgen and I. W. Mathison, J. Pharm. Sci.,65, 467–482 (1976).
P. H. Morgen and I. W. Mathison, Ibid., 637–648.
R. M. Norris, Drugs,11, 409–411 (1976).
P. H. Nelson, A. M. Strosberg, and K. G. Untch, J. Med. Chem.,23, 180–184 (1980).
P. U. Nwangwu, T. L. Holcslaw, H. Rosenberg, et al., J. Pharm. Pharmacol.,31, 488–489 (1979).
E. Oppenheimer, E. Kaplinsky, N. Kari, et al., Angiology,31, 410–426 (1980).
W. Osswald, S. Guimaraes, and J. Garrett, J. Pharmacol. Exp. Ther.,174, 315–322 (1970).
J. C. Pamintuan, L. S. Dreifus, and J. Watanabe, Amer. J. Cardiol.,26, 512–516 (1970).
I. J. Pianto and A. M. Mondear, Indian Heart J.,28, 80–85 (1976).
J. Piessent, H. Kesteloot, and H. D. Geest, Arzneimittel.-Forsch.,20, 355–358 (1970).
H. Refsun, Europ. J. Pharmacol.,33, 47 (1975).
D. C. Remy, W. A. Saun, E. L. Engelhardt, et al., J. Med. Chem.,18, 142–148 (1975).
C. P. Robinson and B. V. Rama Sastry,. Ibid.,15, 870–872 (1972).
R. D. Robson and H. R. Kaplan, J. Pharmacol. Exp. Ther.,175, 157–177 (1970).
J. J. Rosanski, L. Zaman, and A. Castellanis, Amer. J. Cardiol.,49, 621–628 (1982).
H. J. Rüdiger, H. Homburger, and H. Antoni, Naunyn-Schmiedeberg's Arch. Pharmacol.,317, 238–244 (1981).
P. C. Ruenitz and C. M. Mokler, J. Med. Chem.,20, 1668–1671 (1977).
L. Ryden, A. Hjalmarsaon, H. Wasir, and L. Werko, Brit. Heart J.,36, 811–821 (1974).
H. Sachs and B. M. Kennelly, Brit. Med. J.,2, 716–721 (1972).
M. Sakahashi, J. Yoshikawa, R. Akiyoshi, et al., Arrneimittel.-Forsch.,33, 215–218 (1983).
R. Saner, Therapie,25, 393–401 (1970).
W. K. A. Schapor, R. Xhoneux, A. H. M. Jagenseau, and P. A. J. Janssen, J. Pharmacol. Exp. Ther.,151, 265–274 (1966).
C. F. Schwender, S. Farber, C. Blaum, et al., J. Med. Chem.,13, 684–688 (1970).
B. N. Singh, G. Ellrodt, and C. T. Peter, Drugs,15, 169–197 (1978).
B. N. Singh, and O. Hauswirth, Amer, Heart J.,87, 367–383 (1974).
B. N. Singh and R. Jewitt, Drugs,7, 426–461 (1974).
B. N. Singh, K. Nadelmane, and S. H. Baky, Ibid.,25, 125–153 (1983).
B. N. Singh and E. M. Williams, Brit. J. Pharmacol.,38, 748–757 (1970).
B. N. Singh and E. M. Williams, Ibid.,44, 1–9 (1972).
D. N. Singer and R. E. Ten-Eick, Progr. Cardiovasc. Dis.,24, 91–96 (1981).
L. D. Small, H. Rosenberg, P. U. Nwangwu, et al., J. Med. Chem.,22, 1014–1016 (1979).
J. L. Southworth, V. A. McKusick, and E. C. Pierce, J.A.M.A.,143, 717 (1950).
S. Stern, H. Milvidsky, and J. B. Borman, J. Clin. Pharmacol.,11, 409–412 (1971).
H. Sterr, Wien. Klin. Wschr.,82, 894–899 (1970).
D. M. Stout, W. L. Matier, C. Barcelon-Janh, et al., J. Med. Chem.,26, 808–813 (1983).
C. J. Sun, X. Y. Zhang, X. Z. Yang, et al., Acta Pharm. Sin.,16, 564–570 (1981).
T. Sugimoto, T. Ishikawa, K. Kasena, et al., Angiology,31, 700–709 (1980).
I. V. Talano and D. Feerst, Arch. Intern. Med.,140, 314–315 (1980).
R. G. Talbot, Amer. Heart J.,89, 537–538 (1975).
R. G. Talbot, R. A. Clark, J. Nimmo, et al., Lancet,2, 399–403 (1973).
K. Theisen, Dtsch. Med. Wschr.,108, 1021–1027 (1983).
P. A. Tenthorey, H. J. Adams, G. H. Kronberg, and G. H. Takman, J. Med. Chem.,24, 1059–1063 (1981).
P. A. Tenthorey, A. J. Block, R. A. Ronfeld, et al., Ibid., 798–806.
P. A. Tenthorey, R. L. Rubio, H. S. Feldman, et al., Ibid.,22, 182 (1979).
B. Terhaag and W. Forster, Pharmazie,31, 635 (1976).
W. Trautwein, D. Pelzer, T. F. McDonald, and W. Osterrieder, Naunyn-Schmiedeberg's Arch. Pharmacol.,317, 228 (1981).
A. T. Trompler and W. D. Bussmann, Arzneimittel.-Forsch.,33, 436–439 (1983).
K. Van Dongen, Arch. Int. Pharmacodyn.,96, 45–48 (1953).
P. D. Verdouw, Arzneimittel.-Forsch.,26, 1558–1561 (1976).
P. D. Verdouw, H. P. A. Bom, and R. E. Bijleveed, Ibid.,33, 702–706 (1983).
A. P. Viana and R. Osswald, Ibid.,20, 851–853 (1970).
H. Vidro, M. A. Mena, and E. Hong, Ibid.,30, 12–17 (1980).
J. De Vries, W. T. Nauta, H. Timmerman, et al., Ibid.Arzneimittel.-Forsch.,18, 1200–1203 (1968).
C. Wang et al., Pharmacologist, 19, Abstr., 146 (1977).
E. Waterloh, H. F. Rittel, and E. Leide, Arzneimittel.-Forsch.,19, 153–159 (1969).
D. G. Wenzel and J. E. Kloeppel, Pharmacol. Res. Commun.,12, 863–871 (1980).
M. Wilhelm, P. Hedwall, and M. Meier, Experientia,23, 651–652 (1967).
F. A. Willins and T. E. Keys, Proc. Mayo Clin.,17, 294–296 (1942). Cited in L. S. Goodman and A. Gilman, The Pharmacological Basis of Therapeutics, 5th Edn. (1975), p. 686.
W. Winkler, Arzneimittel.-Forsch.,33, 279–280 (1983).
Ch. H. Yeh, H. S. Lowrie, and R. R. Dean, J. Med. Chem.,17, 1131–1135 (1974).
B. K. Yeh, P. K. Sung, and B. J. Scherlag, J. Phann. Sci.,62, 1224–1229 (1979).
K. Zoeten, J. C. A. Meel, J. E. Kemenade, et al., Arzneimittel.-Forsch.,33, 694–698 (1983).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 19, No. 11, pp. 1306–1321, November, November, 1985.
Rights and permissions
About this article
Cite this article
Yakhonmov, L.N., Liberman, S.S. Agents for the treatment of cardiovascular diseases. Pharm Chem J 19, 747–761 (1985). https://doi.org/10.1007/BF00766629
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00766629